García-Magallón Belén, Cobo-Marcos Marta, Martiarena Aitor Dávila, Hernández Esther Montero, Martín Jiménez Maria Luisa, García Aránzazu Martín, De Castro Campos Daniel, Martín Paula Vela, Terciado Fernando Hernández, González Ramón Garrido, Matutano Muñoz Andrea, Escribano García Daniel, Domínguez Fernando, Sainz Herrero Ana, Gómez Peñalba Camino, Garcia-Pavia Pablo, Segovia Javier
Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Front Physiol. 2022 May 2;13:887734. doi: 10.3389/fphys.2022.887734. eCollection 2022.
European Guidelines recommend early evaluation of diuresis and natriuresis after the first administration of diuretic to identify patients with insufficient diuretic response during acute heart failure. The aim of this work is to evaluate the prevalence and characteristics of patients with insufficient diuretic response according to this new algorithm. Prospective observational single centre study of consecutive patients with acute heart failure and congestive signs. Clinical evaluation, echocardiography and blood tests were performed. Diuretic naïve patients received 40 mg of intravenous furosemide. Patients on an oupatient diuretic regimen received 2 times the ambulatory dose. The diuresis volume was assessed 6 h after the first loop diuretic administration, and a spot urinary sample was taken after 2 h. Insufficient diuretic response was defined as natriuresis <70 mEq/L or diuresis volume <600 ml. From January 2020 to December 2021, 73 patients were included (59% males, median age 76 years). Of these, 21 patients (28.8%, 95%CI 18.4; 39.2) had an insufficient diuretic response. Diuresis volume was <600 ml in 13 patients (18.1%), and 12 patients (16.4%) had urinary sodium <70 mEq/L. These patients had lower systolic blood pressure, worse glomerular filtration rate, and higher aldosterone levels. Ambulatory furosemide dose was also higher. These patients required more frequently thiazides and inotropes during admission. The diagnostic algorithm based on diuresis and natriuresis was able to detect up to 29% of patients with insufficient diuretic response, who showed some characteristics of more advanced disease.
欧洲指南建议在首次使用利尿剂后尽早评估利尿和利钠情况,以识别急性心力衰竭期间利尿剂反应不足的患者。这项研究的目的是根据这一新算法评估利尿剂反应不足患者的患病率和特征。对连续的急性心力衰竭和充血体征患者进行前瞻性观察单中心研究。进行了临床评估、超声心动图检查和血液检查。未使用过利尿剂的患者静脉注射40毫克呋塞米。接受门诊利尿剂治疗方案的患者接受2倍门诊剂量。在首次使用袢利尿剂6小时后评估尿量,并在2小时后采集随机尿样。利尿剂反应不足的定义为尿钠排泄<70 mEq/L或尿量<600毫升。2020年1月至2021年12月,共纳入73例患者(男性占59%,中位年龄76岁)。其中,21例患者(28.8%,95%CI 18.4;39.2)利尿剂反应不足。13例患者(18.1%)尿量<600毫升,12例患者(16.4%)尿钠<70 mEq/L。这些患者的收缩压较低,肾小球滤过率较差,醛固酮水平较高。门诊呋塞米剂量也较高。这些患者在住院期间更频繁地需要噻嗪类药物和正性肌力药物。基于利尿和利钠的诊断算法能够检测出高达29%的利尿剂反应不足患者,这些患者表现出一些疾病进展更严重的特征。